UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis

Cancer discovery, 2017-07, Vol.7 (7), p.694-703

2017

Volltextzugriff (PDF)

Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression

The Journal of immunology (1950), 2012-11, Vol.189 (9), p.4674-4683

2012

Volltextzugriff (PDF)

Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators

Vaccine, 2011-09, Vol.29 (41), p.7130-7135

2011

Volltextzugriff (PDF)

Poly(Anhydride) Nanoparticles Act as Active Th1 Adjuvants through Toll-Like Receptor Exploitation

Clinical and Vaccine Immunology, 2010-09, Vol.17 (9), p.1356-1362

2010

Volltextzugriff (PDF)

The involvement of ADAM10 in acantholysis in mucocutaneous pemphigus vulgaris depends on the autoantibody profile of each patient

British journal of dermatology (1951), 2020-05, Vol.182 (5), p.1194-1204

2020

Volltextzugriff (PDF)

Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance

Liver transplantation, 2013-09, Vol.19 (9), p.937-944

2013

Volltextzugriff (PDF)

Genetic Modification of CD8 + T Cells to Express EGFR: Potential Application for Adoptive T Cell Therapies

Frontiers in immunology, 2019-12, Vol.10, p.2990-2990

2019

Volltextzugriff (PDF)

Mutated trimeric RBD vaccines: a platform against variants of concern

Signal transduction and targeted therapy, 2023-04, Vol.8 (1), p.161-161, Article 161

2023

Volltextzugriff (PDF)

Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies

Frontiers in immunology, 2023-01, Vol.13, p.1044025-1044025

2023

Volltextzugriff (PDF)

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer

Frontiers in immunology, 2022-11, Vol.13, p.985886-985886

2022

Volltextzugriff (PDF)

Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies

Frontiers in immunology, 2023-03, Vol.14, p.1172427-1172427

2023

Volltextzugriff (PDF)

T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates

Gene therapy, 2016-10, Vol.23 (10), p.753-759

2016

Volltextzugriff (PDF)

Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model

Cancer Immunology, Immunotherapy, 2019-03, Vol.68 (3), p.379-393

2019

Volltextzugriff (PDF)

Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses

Emerging microbes & infections, 2021-01, Vol.10 (1), p.1931-1946

2021

Volltextzugriff (PDF)

CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination

The Journal of immunology (1950), 2003-12, Vol.171 (11), p.5931-5939

2003

Volltextzugriff (PDF)

Skin lesion caused by ST398 and ST1 MRSA, Spain

Emerging infectious diseases, 2010-01, Vol.16 (1), p.157-159

2010

Volltextzugriff (PDF)

Identification of CD4+ and CD8+ T cell epitopes of woodchuck hepatitis virus core and surface antigens in BALB/c mice

Vaccine, 2010-07, Vol.28 (32), p.5323-5331

2010

Volltextzugriff (PDF)

Upregulation of Indoleamine 2,3-Dioxygenase in Hepatitis C Virus Infection

Journal of Virology, 2007-04, Vol.81 (7), p.3662-3666

2007

Volltextzugriff (PDF)

Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma

Nature medicine, 2023-03, Vol.29 (3), p.632-645

2023

Volltextzugriff (PDF)

Analysis of copy number alterations reveals the lncRNA ALAL-1 as a regulator of lung cancer immune evasion

The Journal of cell biology, 2020-09, Vol.219 (9)

2020

Volltextzugriff (PDF)

Genetic Basis for Clinical Response to CTLA-4 Blockade

The New England journal of medicine, 2015-02, Vol.372 (8), p.783-783

2015

Volltextzugriff (PDF)

FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma

Molecular therapy, 2023-01, Vol.31 (1), p.48-65

2023

Volltextzugriff (PDF)

Foxp3 inhibitory peptide encapsulated in a novel CD25-targeted nanoliposome promotes efficient tumor regression in mice

Acta pharmacologica Sinica, 2024-07

2024

Volltextzugriff (PDF)

PTEN Loss Confers Resistance to Anti-PD-1 Therapy in Non-Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells

Cancer research (Chicago, Ill.), 2023-08, Vol.83 (15), p.2513-2526

2023

Volltextzugriff (PDF)

1 – 25 von 297

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(255)
Mit Volltextzugriff
(256)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(127)
Life Sciences & Biomedicine
(123)
Humans
(94)
Animals
(67)
Female
(64)
Biological And Medical Sciences
(50)
Mice
(50)
Immunology
(49)
Male
(43)
Medical Sciences
(35)
Mice, Inbred Balb C
(25)
Infectious Diseases
(24)
Oncology
(21)
Amino Acid Sequence
(20)
Immunization
(20)
Virology
(20)
Fundamental And Applied Biological Sciences. Psychology
(19)
Molecular Sequence Data
(19)
Cd8-Positive T-Lymphocytes - Immunology
(16)
Hepacivirus - Immunology
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis

Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression

Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators

Poly(Anhydride) Nanoparticles Act as Active Th1 Adjuvants through Toll-Like Receptor Exploitation

The involvement of ADAM10 in acantholysis in mucocutaneous pemphigus vulgaris depends on the autoantibody profile of each patient

Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance

Genetic Modification of CD8 + T Cells to Express EGFR: Potential Application for Adoptive T Cell Therapies

Mutated trimeric RBD vaccines: a platform against variants of concern

Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer

Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies

Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia

T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates

Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model

Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses

CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination

Skin lesion caused by ST398 and ST1 MRSA, Spain

Identification of CD4+ and CD8+ T cell epitopes of woodchuck hepatitis virus core and surface antigens in BALB/c mice

Upregulation of Indoleamine 2,3-Dioxygenase in Hepatitis C Virus Infection

Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma

Analysis of copy number alterations reveals the lncRNA ALAL-1 as a regulator of lung cancer immune evasion

Genetic Basis for Clinical Response to CTLA-4 Blockade

FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma

Foxp3 inhibitory peptide encapsulated in a novel CD25-targeted nanoliposome promotes efficient tumor regression in mice

PTEN Loss Confers Resistance to Anti-PD-1 Therapy in Non-Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells

Suchergebnisse filtern